AVE 25.0% 0.3¢ avecho biotechnology limited

oxymorphone patch m eets phase 1 end points, page-28

  1. 846 Posts.
    My thoughts after todays action. Only sales and strong income figures are going to get the share price ascending. The market clearly doesnt regard the progress as anything overwhelmingly special.

    Oxy patch has potential lets hope we get a good supply deal.
    Looks like its back to the bottom draw.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.